InformedDNA $ 4.5 million funding agreement with safre Investments -
InformedDNA, supplier management Genetics leading benefits and the largest independent network of specialists genetics in the US, today announced that it has reached an agreement of $ 4.5 million financing with safre Investments, a wholly owned subsidiary of Blue Cross Blue Shield of Massachusetts. InformedDNA will use the investment to improve the efficiency and capacity of its genetic management capabilities of the advantages of use due to the increased use of information technology. The funding will also help the company manage its rapid growth.
"InformedDNA will be able to serve patients faster, while improving quality of care and the prevention of waste and excess costs through the investment of one of the most strategic of the nation and before -gardiste health plans, "said David Nixon, InformedDNA general manager." Our use of genetic testing management solutions have been developed by genetics specialists to meet an unmet need for health plans which current systems and partners do not have the specific capacity to serve patients and collaborate with suppliers in the emerging field of personalized medicine. "
genetic testing can be a complicated and expensive process for all concerned. InformedDNA coined the term Genetic Optimization Benefits to reflect its proven approach in clinical practice and the management of genetic benefits. The process engages all genetics specialists throughout the risk assessment and the process of genetic testing to ensure that patients receive appropriate recommendations for testing and other services, improved access and quality while managing the costs of health care.
"The field of genetics continues to grow at a rapid pace and we want to better serve our members in what may be a new still confused exciting field of health care," said Jason Robart, President safre Investments. "unique blend of InformedDNA supplier of services and technology will help ensure doctors and patients receive the support they need to make informed medical decisions on genetic testing."
EmoticonEmoticon